Title: What does the transition state of the neuraminidase-catalyzed reaction look like?
1What does the transition state of the
neuraminidase-catalyzed reaction look like?
2- Note that a key step in the previous mechanism is
the loss of an alkoxy (sugar) moiety from the
position (C2) next to the carboxylate group. - This creates a carbocation (Sn1 process), which
is sp2 hybridized. - The initial substrate is sp3 hybridized at C2
- Thus it was decided to try to synthesize and test
compounds which had a double bond to C2, with the
prospect of identifying something which bound
tighter than the substrate and which could,
therefore, function as an effective inhibitor.
3(No Transcript)
4Chemical evolution of neuraminidase inhibitors
- Note that lower Ki values correspond to more
active inhibitors - The final product, Relenza (Zanamivir), has a
positively charged guanidinium cation
(southern end of molecule) - Thus, it is too polar to be absorbed orally and
must be administered by inhalation.
5(No Transcript)
6Further chemical evolution of neuraminidase
inhibitors
While the C5 substituent (glycerol side chain)
bound to a polar pocket, some of the more recent
analogs have shown there is also a hydrophobic
pocket, which can bind more hydrophobic C5 side
chains, such as the tertiary amide side chain of
I.
7(No Transcript)
8- Note that the actual reaction intermediate
(lower left) involves a resonance-stabilized
carbocation (with oxygen providing electrons to
stabilize the C2 carbocation. - Thus it was decided that the double bond of
Relenza (Zanamivir) might be in a somewhat
incorrect position for optimal binding. - To prepare a stable compound with the double
bond in the optimal position, they had to replace
the oxygen of the six-membered ring with a carbon
(called a carbon isostere). - Note the improvement in activity as the double
bond position is altered.
9Further chemical evolution of neuraminidase
inhibitors
- Thus a series of compounds was prepared having
an appropriately placed CC and an adjacent
hydrophobic group (in this case a substituted
ether linkage). - The most active of these (above) has a branched
side chain (3-pentyl side chain) on the ether. - Due to the improvement in inhibitory activity,
it was possible to remove the highly polar
guanidinium side chain and replace it with a
slightly less polar amine side chain.
10Evolution leading to the final product, Tamiflu.
- The carboxylic acid of GS 4071 is still too
polar. - Thus, they replaced the acid with an ester,
which can be hydrolyzed by esterases. - Compounds related to II (above) are currently in
clinical trials. These seem to show a further
improvement in selectivity against viruses.
11Other Drugs to Treat Influenza
12Antiviral Drugs
- amantadine (Symmetrel) used prophylactically
against influenza A in high-risk individuals. - rimantidine (Flumadine) used for treatment and
prophylaxis of influenza A.
13Mechanism of Action of Amantadine and Rimantadine
- These agents were discovered by random screening
and are now known to interfere with a viral ion
channel called matrix (M2) protein. - This causes an inhibition of uncoating of the
virus. - At high concentrations, they also buffer the pH
of the endosomes and prohibit the acidic
environment needed for Hemagglutinin (HA) to fuse
the viral membrane with that of the endosome.
14(No Transcript)
15What is HSV?
- HSV Herpes Simplex Virus
- HSV-1 is the usual cause of cold sores
- HSV-2 is the usual cause of genital herpes
- Both types look the same under the microscope and
share about 50 of their DNA.
16(No Transcript)
17(No Transcript)
18(No Transcript)
19(No Transcript)
20What is the difference between HSV-1 and HSV-2?
- Both types infect the bodys mucosal surfaces,
usually mouth or genitals, and then establish
latency in the nervous system. - For both types, at least two-thirds of the
infected people have no symptoms, or symptoms too
mild to notice. - However, both types can recur and spread, even
after a period in which there were no symptoms.
21http//www.healthscout.com/animation/68/21/main.ht
mlLinkLink
HSV-1 and HSV-2
22- HSV spends much of its time hiding in a latent
form. - The virus reproduces efficiently in epithelial
cells and it hides in nerve cells.
23- HSV-1 usually establishes latency in the
trigeminal ganglion, a collection of nerve cells
near the ear. Then it tends to recur on the
lower lip or face.
24HSV-2 usually establishes latency in sacral
ganglion at the base of the spine. From there,
it recurs in the genital area.
25(No Transcript)
26- For a virus, the herpes genome includes an
extremely large number of genes (at least 74
genes, or open reading frames ORFs). - About half of these genes code for proteins that
are involved in evading host defenses.
27HSV-1
- One can have HSV-1 both genitally and orally.
- HSV-1 is usually mild, especially when it infects
the lips, face, or genitals. - However, HSV-1 can recur in the eye, causing
ocular herpes, which can lead to blindness, and
can even spread spontaneously to the brain,
causing herpes encephalitis, which can lead to
death.
28HSV-2
- 22 of adult Americans have HSV-2
- Like HSV-1, HSV-2 symptoms are usually mild, so
mild, in fact, that two-thirds of infected people
dont know they have it. - HSV-2 rarely causes complications or spreads to
other parts of the body. - Oral HSV-2 infections are rare. But even when an
infection does occur, recurrent oral outbreaks
are uncommon.
29Transmission of HSV-2
- In the first year of HSV-2 infection, people shed
the virus from the genital area about 6 to 10 of
those days when they are asymptomatic. This
decreases over time and can also be further
lessened by the use of oral medication. Sex
should be avoided in the presence of symptomatic
lesions.
30- Having a previous HSV-1 infection seems to
provide some immunity to an HSV-2 infection.
This is probably the reason that oral HSV-2
infections are rare, given the studies which show
that a significant proportion of the population
practices oral sex.
31How severe an infection?
- HSV is a lifelong illness
- But HSV-2 usually produces only mild symptoms or
signs or no symptoms at all. - However, HSV-2 can cause recurrent painful
genital sores in many adults, and HSV-2 infection
can be severe in people with suppressed immune
systems. - Another factor is how long a person has had the
infection. It seems to decrease in severity over
time, for reasons which are unclear.
32Symptoms
- If signs and symptoms occur during the first
episode, they can be quite pronounced. The first
episode usually occurs within two weeks after the
virus is transmitted, and the sores typically
heal within two to four weeks. - Other signs and symptoms during the primary
episode may include a second crop of sores, or
flu-like symptoms, including fever and swollen
glands.
33Is there a cure?
- There is no treatment that can cure herpes, but
antiviral medications can shorten and prevent
outbreaks during the period of time the person
takes the medication.
34Vaccines?
- No vaccine for HSV-2 is currently available.
35DNA Virus
- Recall that HSV is a DNA virus (influenza was an
RNA virus) - In general, more drugs are available to treat DNA
viruses than for RNA viruses (excluding those
used to treat HIV). - Most of the drugs available for treatment of DNA
viruses have been developed against
herpesviruses. - Diseases include cold sores, genital herpes,
chickenpox, shingles, mononucleosis, etc.
36Antiviral Chemotherapy for HSV
- There are several prescription antiviral
medications for controlling herpes outbreaks,
include acyclovir (Zovirax), valacyclovir
(Valtrex), famcyclovir (Famvir), and pencyclovir.
- Acyclovir was the original and prototypical
member of this class - Valacyclovir and famcyclovir are prodrugs of
acyclovir and pencyclovir respectively, with
improved oral bioavailability.
37Chemotherapy for HSV
Acyclovir (Zovirax)
Valacyclovir (Valtrex),
pencyclovir
Famcyclovir (Famvir),
38Gertrude B. Elion won the Nobel prize in
Physiology or Medicine in 1988, partly for the
discovery of acyclovir.
39Drugs Discovered by Gertrude B. Elion Include
- 6-mercaptopurine (Purinethol), the first
treatment for leukemia. - Azathioprine (Imuran), the first
immuno-suppressive agent, used for organ
transplants. - Allopurinol (Zyloprim), for gout.
- Pyrimethamine (Daraprim), for malaria.
- Trimethoprim (Septra), for meningitis,
septicemia, and bacterial infections of the
urinary and respiratory tracts. - Acyclovir (Zovirax), for viral herpes.
40Mechanism of Action of Antivirals to treat HSV
- Both acyclovir and pencyclovir work by
interfering with viral replication, effectively
slowing the replication rate of the virus, and
providing a greater opportunity for the immune
response to intervene. - All drugs in this class depend on the activity of
the viral thymidine kinase to convert the drug to
a monophosphate form and subsequently interfere
with viral DNA replication.
41Acyclovir (ZOVIRAX)
- Discovered by random compound screening and
introduced into the market in 1981. - It was the first non-toxic herpes drug to be used
systemically. - It is used for the treatment of infections due to
both HSV-1 and HSV-2.
42The Mechanism of Acyclovir
- The genome of the Herpes viridae code for the
production of viral DNA polymerase (rather than
using the host cell DNA polymerase). - The drug interferes with the action of the viral
DNA polymerase, with high selectivity over that
of the host enzyme. - Additionally, to be activated the drug must first
be phosphorylated. This is achieved by viral
thymidine kinase, which is less selective than
cellular thymidine kinase.
43(No Transcript)
44- Aciclovir interferes with DNA synthesis, but
must first become activated. - To become activated, Aciclovir must be
phosphorylated (3x) - However, Aciclovir itself is not a good
substrate for mammalian kinases, thus it relies
on the viral thymidine kinase to become
phosphorylated the first time. - This is good, since the drug cannot interfere
with DNA synthesis in cells that are not infected
with the virus, thus reducing the toxicity of the
drug. - The second and third phosphorylations, however,
are performed by the cellular thymidylate kinase.
45- Aciclovir triphosphate is mistaken for
deoxyguanosine triphosphate. - However, since it lacks the 3-OH group, it
cannot be linked to the adjacent residue in the
usual fashion.
46(No Transcript)
47http//www.dnalc.org/ddnalc/resources/sangerseq.ht
ml
- The mechanism of action of Acyclovir is analogous
to that utilized by Fred Sangers method of DNA
sequencing. - http//www.dnalc.org/view/15479-Sanger-method-of-D
NA-sequencing-3D-animation-with-narration.html - http//www.biostudio.com/demo_freeman_dna_sequenci
ng.htm
48Valacyclovir
- Valaciclovir is an esterified version of
aciclovir, that has greater oral bioavailability.
49Penciclovir
- Penciclovir is used primarily as a cream (it has
poor oral bioavailability) to treat herpesvirus
infections. - It is the active ingredient in the cold sore
medications Denavir and Fenistil..
50Famciclovir
- Famciclovir is a di-esterified version of
penciclovir - The ester groups give the drug better oral
bioavailability - To treat shingles, it is taken three times a day
for seven days. - To treat genital herpes, it is taken twice a day
for five days.
51Major members of the herpesvirus group of the
family Herpesviridae
- Herpes simplex viruses HSV-1 and HSV-2
- Cytomegalovirus (CMV)
- Varicella-zoster virus (VZV)
- Epstein-Barr virus (EBV)
52Varicella-zoster virus (VZV)
- The Varicella zoster virus (VZV) is one of the
eight herpes viruses known to affect humans (and
other vertebrates). It commonly causes chickenpox
in children and shingles later in life.
53Shingles
54Treatment of Varicella Infection
- Acyclovir has been shown to reduce fever and skin
lesions in patients with varicella and it use is
recommended in healthy patients over 18 years of
age.
Acyclovir (ZOVIRAX)
55Cytomegalovirus
- Cytomegalovirus (CMV) is a common virus that
infects most people during their life. Most
people are infected in early childhood (under 3
years of age) or in the teenage years. Usually
there are no symptoms of CMV infection.
56Link
- Since most CMV infections are mild and usually do
not cause long-term problems, most people don't
even know they are infected. - However, CMV can cause problems in a developing
baby if the mother gets the infection during
pregnancy.
57Cytomegalovirus (CMV)
- After a person has a CMV infection, the virus
stays in the body but is not active. The virus
can reactivate months or years later, which
occurs most often when a person's immune system
is weakened.
58Cytomegalovirus (CMV)
- Anyone with a weakened immune system is at risk
for problems with CMV infection. A weakened
immune system can be related to infection with
the human immunodeficiency virus (HIV) or medical
treatments. - Medical treatments that can weaken the immune
system include chemotherapy, radiation therapy,
steroids, and stem cell or organ
transplantation.
59Cytomegalovirus (CMV)
- A few people will have symptoms such as sore
throat, fever, headache and fatigue. People who
have weakened immune systems may develop severe
symptoms, such as pneumonia or infections of the
eyes, liver, or intestinal tract. People with HIV
infection should be sure to let their doctor know
if they are having any painless blurring of their
vision, "floaters" in the eye, light flashes,
areas of blindness, or shortness of breath.
60Treatment of CMV Infection
- Gangiclovir, a nucleoside analog of acyclovir,
inhibits CMV replication and reduces the severity
of CMV syndromes, such as retinitis and
gastrointestinal disease.
Deoxyguanosine
Acyclovir
Gangciclovir
61Ganciclovir
Ganciclovir is used to treat or prevent
cytomegalovirus
62Gangciclovir for ocular use is marketed under the
trade name Vitrasert.
63Valganciclovir
Valganciclovir is a more orally bioavailable
version of this drug.
64Epstein-Barr Virus (EBV)
- EBV is the etiologic agent of infectious
mononucleosis - Symptoms include fever, tender lymph nodes, sore
throat, mental fatigue - Treatment is usually supportive
- Acyclovir can decrease replication of EBV in
culture, but has little impact on clinical
illness.
65Assigned Reading
- Wasik, Mitzi Kachlic, Marlowe Djuric. A review
of common sexually transmitted diseases.
Formulary (2009), 44(3), 78-85. - De Clercq, Erik Field, Hugh J. Antiviral
prodrugs - the development of successful prodrug
strategies for antiviral chemotherapy. British
Journal of Pharmacology (2006), 147(1), 1-11.
66Homework Questions
- Describe the methods used for diagnostic testing
for HSV. - List the accepted treatment for this disease.
- From one point of view, all antiviral nucleosides
can be considered prodrugs. Explain. What
enzyme do they require for activation? - What two undesirable properties of acyclovir
(ACV) prompted the search for a prodrug? - What protein is responsible for the improved
bioavailability of valaciclovir? - Gangiciclovir (GCV) has superior activity than
acyclovir against which virus? - Oseltamivir (Tamiflu) is also a prodrug. Which
functionality will be transformed in vivo? Why
was this functionality incorporated?